LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

LLY

910.17

+0.51%↑

UNH

569.99

-0.12%↓

NVO

116.46

-0.73%↓

JNJ

163.54

+0.57%↑

ABBV

188.97

+1.46%↑

Accueil・Liste d'Actions・Ardelyx Inc

Ardelyx Inc

Fermé

Secteur Soins de santé

5.77 -1.7

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

5.65

Max

5.88

Chiffres clés
By Trading Economics
Revenu	-27M
Ventes	12M 46M
BPA	-0.11
Marge bénéficiaire	-57.619
Employés	267
EBITDA	-22M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+78.57 upside

Dividendes
By Dow Jones
Prochains Résultats	31 oct. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-228M 1.4B
Ouverture précédente	7.47
Clôture précédente	5.77

Sentiment de l'Actualité

By Acuity

14%

86%

15 / 390 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

5.85 / 5.925 Support & Résistance

Ardelyx Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 oct. 2024, 21:55 UTC

Principaux Mouvements du Marché

McDonald's Shares Fall After CDC Says E. Coli Outbreak Linked to Quarter Pounders -- Update

22 oct. 2024, 21:48 UTC

Actualités

CDC Says E. Coli Outbreak Linked to McDonald's Quarter Pounders -- Update

22 oct. 2024, 21:37 UTC

Principaux Mouvements du Marché

DBV Technologies Rally 47% Following Positive Updates for Peanut Allergy Patch

22 oct. 2024, 21:30 UTC

Principaux Mouvements du Marché

McDonald's Shares Fall After CDC Says E. Coli Outbreak Linked to Quarter Pounders

22 oct. 2024, 21:12 UTC

Actualités

CDC Says E. Coli Outbreak Linked to McDonald's Quarter Pounders

22 oct. 2024, 20:52 UTC

Actualités

Résultats

Starbucks Suspends Guidance After Sales Slump Persists

22 oct. 2024, 20:49 UTC

Actualités

Résultats

Canadian National Railway Posts Higher Revenue, Lower Profit in 3Q

22 oct. 2024, 20:28 UTC

Résultats

Texas Instruments Posts Lower 3Q Revenue

22 oct. 2024, 23:24 UTC

Actualités

Résultats

Starbucks Suspends Guidance as Sales Slump Persists -- 2nd Update

22 oct. 2024, 22:54 UTC

Market Talk

Global Equities Roundup: Market Talk

22 oct. 2024, 22:53 UTC

Market Talk

CSL's R&D Update Seen as Neutral Overall -- Market Talk

22 oct. 2024, 22:46 UTC

Actualités

Meta Bans Accounts That Track Celebrity Jet Travel, Including for Zuckerberg -- WSJ

22 oct. 2024, 22:45 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- 3rd Update

22 oct. 2024, 21:58 UTC

Actualités

Résultats

Starbucks Suspends Guidance as Sales Slump Persists -- Update

22 oct. 2024, 21:53 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- 2nd Update

22 oct. 2024, 21:19 UTC

Actualités

Texas Instruments' Guidance Falls Short. The Stock Is Rising Anyway. -- Barrons.com

22 oct. 2024, 21:14 UTC

Actualités

Résultats

3M Produces Beat-and-Raise Earnings. The Stock Dropped. -- Barrons.com

22 oct. 2024, 21:05 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- Update

22 oct. 2024, 20:55 UTC

Résultats

Philip Morris International Stock Surges to Record -- WSJ

22 oct. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

22 oct. 2024, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

22 oct. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 oct. 2024, 20:48 UTC

Actualités

McDonald's Quarter Pounders Linked to Deadly E. Coli Outbreak -- WSJ

22 oct. 2024, 20:45 UTC

Actualités

Treasury Yields Rise, S&P 500 Edges Lower After Earnings Flurry -- WSJ

22 oct. 2024, 20:45 UTC

Résultats

GE Aerospace Stock Skids Amid Commercial-Engine Concerns -- WSJ

22 oct. 2024, 20:34 UTC

Actualités

Résultats

Starbucks Stock Drops After Company Misses Earnings, Suspends Guidance -- Barrons.com

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects 4Q U.S. Drilling Lower 48 Avg Rig Count of Approximately 68 Rigs >NBR

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects Full-Yr Cap Expenditures of Approximately $600M, With $230M for the SANAD Newbuilds >NBR

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects 4Q International Avg Rig Count of Approximately 84 Rigs >NBR

22 oct. 2024, 20:22 UTC

Résultats

Nabors: Expects 4Q Cap Expenditures of $230M, With $105M for the Newbuilds in Saudi Arabia >NBR

Comparaison

Variation de prix

Ardelyx Inc prévision

Objectif de Prix

By TipRanks

78.57% hausse

Prévisions sur 12 Mois

Moyen 10.5 USD 78.57%

Haut 12 USD

Bas 7 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

Achat

Maintien

Vente

Basé sur 6 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

5.85 / 5.925Support & Résistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

15 / 390Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Ardelyx Inc

Ardelyx, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of medicines to improve treatment for people with kidney and cardiorenal diseases. The Company's product pipeline includes Tenapanor, IBSRELA, RDX013 Program, and RDX020 Program. The Tenapanor is a medicine for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor for the control of serum phosphorus has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). RDX013 Program is a small molecule potassium secretagogue program for the potential treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis. It has a discovery program targeting the inhibition of intestinal bicarbonate exchange for the treatment of metabolic acidosis.